In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Jomed NV invests in Pathway Medical and CardioPath

Executive Summary

Jomed NV (IVUS and other MIS vascular interventional technology) has licensed exclusive rights in Europe, Japan, and other world markets outside the US, to Pathway Medical Technologies' CardioPath debulking system, a catheter-based drilling device that opens diseased and clogged arteries and bypass grafts, usually so stents can be placed.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • R&D and Marketing (Licensing)

Related Companies